Lisa Wilson | Investor Relations |
Scott Tarriff | Chief Executive Officer |
Pete Meyers | Chief Financial Officer |
David Amsellem | Piper Jaffray |
Randall Stanicky | RBC Capital Markets |
Tim Lugo | William Blair |
Good day and welcome to today’s program. My name is Keith and I will be your conference operator today. At this time, I would like to welcome everyone to Eagle Pharmaceuticals’ Fourth Quarter and Full Year 2017 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period.